MoneyWorks4Me

CORONA Remedies - Quaterly Results

12 May 2026 Evaluate
The company witnessed a 20.23% growth in the revenue at Rs. 3530.90 millions for the quarter ended March 2026 as compared to Rs. 2936.90 millions during the year-ago period.A good growth in profit of 43.75% reported to Rs. 450.50  millions over Rs. 313.40 millions of corresponding previous quarter.Operating profit surged to 661.30 millions from the corresponding previous quarter of 556.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3530.90 2936.90 20.23 14031.80 11964.20 17.28 14031.80 11964.20 17.28
Other Income 41.10 14.20 189.44 106.50 59.30 79.60 106.50 59.30 79.60
PBIDT 661.30 556.40 18.85 3040.90 2459.10 23.66 3040.90 2459.10 23.66
Interest 13.80 22.00 -37.27 69.70 106.00 -34.25 69.70 106.00 -34.25
PBDT 647.50 534.40 21.16 2780.20 2353.10 18.15 2780.20 2353.10 18.15
Depreciation 102.90 100.40 2.49 378.70 371.60 1.91 378.70 371.60 1.91
PBT 544.60 434.00 25.48 2401.50 1981.50 21.20 2401.50 1981.50 21.20
TAX 94.10 120.60 -21.97 553.00 491.00 12.63 553.00 491.00 12.63
Deferred Tax 51.80 28.20 83.69 38.20 43.00 -11.16 38.20 43.00 -11.16
PAT 450.50 313.40 43.75 1848.50 1490.50 24.02 1848.50 1490.50 24.02
Equity 611.60 611.60 0.00 611.60 611.60 0.00 611.60 611.60 0.00
PBIDTM(%) 18.73 18.95 -1.14 21.67 20.55 5.44 21.67 20.55 5.44
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..